Thais Peclat

863 total citations
21 papers, 362 citations indexed

About

Thais Peclat is a scholar working on Physiology, Radiology, Nuclear Medicine and Imaging and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Thais Peclat has authored 21 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 8 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Thais Peclat's work include Calcium signaling and nucleotide metabolism (10 papers), Cardiac Imaging and Diagnostics (8 papers) and Advanced MRI Techniques and Applications (6 papers). Thais Peclat is often cited by papers focused on Calcium signaling and nucleotide metabolism (10 papers), Cardiac Imaging and Diagnostics (8 papers) and Advanced MRI Techniques and Applications (6 papers). Thais Peclat collaborates with scholars based in United States, Brazil and Uruguay. Thais Peclat's co-authors include Eduardo N. Chini, Claudia C.S. Chini, Gina M. Warner, Mariana G. Tarragó, Kelly A. Hogan, James L. Kirkland, Tamar Tchkonia, Ana Carolina Souza, Katie L. Thompson and Sonu Kashyap and has published in prestigious journals such as Journal of Neuroscience, Circulation Research and Scientific Reports.

In The Last Decade

Thais Peclat

20 papers receiving 356 citations

Peers

Thais Peclat
Thais Peclat
Citations per year, relative to Thais Peclat Thais Peclat (= 1×) peers Iwona Pelikant‐Małecka

Countries citing papers authored by Thais Peclat

Since Specialization
Citations

This map shows the geographic impact of Thais Peclat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thais Peclat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thais Peclat more than expected).

Fields of papers citing papers by Thais Peclat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thais Peclat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thais Peclat. The network helps show where Thais Peclat may publish in the future.

Co-authorship network of co-authors of Thais Peclat

This figure shows the co-authorship network connecting the top 25 collaborators of Thais Peclat. A scholar is included among the top collaborators of Thais Peclat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thais Peclat. Thais Peclat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peclat, Thais, Guillermo Agorrody, Sonu Kashyap, et al.. (2024). Ecto-CD38-NADase inhibition modulates cardiac metabolism and protects mice against doxorubicin-induced cardiotoxicity. Cardiovascular Research. 120(3). 286–300. 5 indexed citations
2.
Shi, Bo, Asif Amin, Pranjali Dalvi, et al.. (2023). Heavy-chain antibody targeting of CD38 NAD+ hydrolase ectoenzyme to prevent fibrosis in multiple organs. Scientific Reports. 13(1). 22085–22085. 5 indexed citations
3.
Zeidler, Julianna D., Kelly A. Hogan, Guillermo Agorrody, et al.. (2022). The CD38 glycohydrolase and the NAD sink: implications for pathological conditions. American Journal of Physiology-Cell Physiology. 322(3). C521–C545. 49 indexed citations
4.
Agorrody, Guillermo, Thais Peclat, Wim van Schooten, et al.. (2022). Benefits in cardiac function by CD38 suppression: Improvement in NAD+ levels, exercise capacity, heart rate variability and protection against catecholamine-induced ventricular arrhythmias. Journal of Molecular and Cellular Cardiology. 166. 11–22. 15 indexed citations
5.
Chini, Claudia C.S., Thais Peclat, Lilian Sales Gomez, et al.. (2022). Dihydronicotinamide Riboside Is a Potent NAD+ Precursor Promoting a Pro-Inflammatory Phenotype in Macrophages. Frontiers in Immunology. 13. 840246–840246. 13 indexed citations
6.
Langley, Monica R., Thais Peclat, Yong Guo, et al.. (2021). Critical Role of Astrocyte NAD + Glycohydrolase in Myelin Injury and Regeneration. Journal of Neuroscience. 41(41). 8644–8667. 23 indexed citations
7.
Zhang, Yingyi, Jielu Hao, Mariana G. Tarragó, et al.. (2021). FBF1 deficiency promotes beiging and healthy expansion of white adipose tissue. Cell Reports. 36(5). 109481–109481. 23 indexed citations
8.
Zhang, Yingyi, Jielu Hao, Mariana G. Tarragó, et al.. (2021). FBF1 Deficiency Promotes Beiging and Healthy Expansion of White Adipose Tissue. SSRN Electronic Journal. 2 indexed citations
9.
Agorrody, Guillermo, Thais Peclat, Lilian Sales Gomez, et al.. (2020). Abstract 452: Role of CD38 in Cardiovascular Performance and Its Use as a Therapeutic Target in Obesity-Induced Diastolic Dysfunction. Circulation Research. 127(Suppl_1).
10.
Peclat, Thais, Bo Shi, John Varga, & Eduardo N. Chini. (2020). The NADase enzyme CD38: an emerging pharmacological target for systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritis. Current Opinion in Rheumatology. 32(6). 488–496. 20 indexed citations
11.
Chini, Claudia C.S., Kelly A. Hogan, Gina M. Warner, et al.. (2019). The NADase CD38 is induced by factors secreted from senescent cells providing a potential link between senescence and age-related cellular NAD+ decline. Biochemical and Biophysical Research Communications. 513(2). 486–493. 91 indexed citations
12.
Peclat, Thais, et al.. (2019). The additional prognostic value of myocardial perfusion SPECT in patients with known coronary artery disease with high exercise capacity. Journal of Nuclear Cardiology. 28(5). 2056–2066. 6 indexed citations
13.
Souza, Ana Carolina, et al.. (2018). The Prognostic Value and Clinical Use of Myocardial Perfusion Scintigraphy in Asymptomatic Patients after Percutaneous Coronary Intervention. Arquivos Brasileiros de Cardiologia. 111(6). 784–793. 3 indexed citations
14.
Peclat, Thais, et al.. (2017). Prognostic performance of coronary computed tomography angiography in asymptomatic individuals as compared to symptomatic patients with an appropriate indication. Journal of cardiovascular computed tomography. 11(2). 148–152. 7 indexed citations
15.
Lima, Ronaldo S.L., et al.. (2017). Prognostic value of a faster, low-radiation myocardial perfusion SPECT protocol in a CZT camera. International journal of cardiac imaging. 33(12). 2049–2056. 9 indexed citations
16.
Peclat, Thais, et al.. (2016). Comparison of the prognostic value of myocardial perfusion imaging using a CZT-SPECT camera with a conventional anger camera. Journal of Nuclear Cardiology. 24(1). 245–251. 22 indexed citations
17.
Peclat, Thais, et al.. (2016). Prevalence and predictors of left intraventricular dyssynchrony determined by phase analysis in patients undergoing gatedSPECT myocardial perfusion imaging. International journal of cardiac imaging. 32(5). 845–852. 9 indexed citations
18.
Lorenzo, Andrea De, Thais Peclat, Ana Carolina Souza, & Ronaldo S.L. Lima. (2015). Prognostic evaluation in obese patients using a dedicated multipinhole cadmium-zinc telluride SPECT camera. International journal of cardiac imaging. 32(2). 355–361. 12 indexed citations
20.
Peclat, Thais, et al.. (2013). Prognostic value of myocardium perfusion imaging with a new reconstruction algorithm. Journal of Nuclear Cardiology. 21(1). 149–157. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026